dilazep has been researched along with Cancer of Prostate in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Passer, BJ | 1 |
| Cheema, T | 1 |
| Zhou, B | 1 |
| Wakimoto, H | 1 |
| Zaupa, C | 1 |
| Razmjoo, M | 1 |
| Sarte, J | 1 |
| Wu, S | 1 |
| Wu, CL | 1 |
| Noah, JW | 1 |
| Li, Q | 1 |
| Buolamwini, JK | 1 |
| Yen, Y | 1 |
| Rabkin, SD | 1 |
| Martuza, RL | 1 |
1 other study available for dilazep and Cancer of Prostate
| Article | Year |
|---|---|
Identification of the ENT1 antagonists dipyridamole and dilazep as amplifiers of oncolytic herpes simplex virus-1 replication.
Topics: Animals; Combinatorial Chemistry Techniques; Dilazep; Dipyridamole; Equilibrative Nucleoside Transpo | 2010 |